UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections

International journal of antimicrobial agents, 2020-12, Vol.56 (6), p.106210, Article 106210

2020

Volltextzugriff (PDF)

Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0082623-e0082623

2023

Volltextzugriff (PDF)

Trowels and Tribulations: Review of Antimicrobial‐Impregnated Bone Cements in Prosthetic Joint Surgery

Pharmacotherapy, 2017-12, Vol.37 (12), p.1565-1577

2017

Volltextzugriff (PDF)

Incidence and Predictors of Gram-Negative Bacilli in Hospitalized People Who Inject Drugs with Injection Drug Use-Attributable Infections

Antimicrobial agents and chemotherapy, 2021-11, Vol.65 (12), p.e0092521-e0092521

2021

Volltextzugriff (PDF)

Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections

International journal of antimicrobial agents, 2021-05, Vol.57 (5), p.106329-106329, Article 106329

2021

Volltextzugriff (PDF)

Ceftriaxone versus cefepime or carbapenems for definitive treatment of low-risk AmpC-Harboring Enterobacterales bloodstream infections in hospitalized adults: A retrospective cohort study

Diagnostic microbiology and infectious disease, 2025-01, Vol.111 (1), p.116557, Article 116557

2025

Volltextzugriff (PDF)

Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe Infections

Pharmacotherapy, 2019-08, Vol.39 (8), p.809-815

2019

Volltextzugriff (PDF)

Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis

The Journal of infectious diseases, 2020-10, Vol.222 (Supplement_5), p.S506-S512

2020

Volltextzugriff (PDF)

Candida spp. infective endocarditis: Characteristics and outcomes of twenty patients with a focus on injection drug use as a predisposing risk factor

Mycoses, 2021-02, Vol.64 (2), p.181-186

2021

Volltextzugriff (PDF)

Clinical Utility of Lefamulin: If Not Now, When?

Current infectious disease reports, 2020, Vol.22 (9), p.25-25, Article 25

2020

Volltextzugriff (PDF)

Aminopenicillins vs non-aminopenicillins for treatment of enterococcal lower urinary tract infections

International journal of antimicrobial agents, 2023-06, Vol.61 (6), p.106800-106800, Article 106800

2023

Volltextzugriff (PDF)

Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors

Antiviral therapy, 2019-01, Vol.24 (6), p.459-465

2019

Volltextzugriff (PDF)

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

International journal of antimicrobial agents, 2016-07, Vol.48 (1), p.56-60

2016

Volltextzugriff (PDF)

Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients With Diabetic Foot Infections

Open forum infectious diseases, 2022-07, Vol.9 (7), p.ofac297-ofac297

2022

Volltextzugriff (PDF)

Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam

Journal of clinical microbiology, 2017-01, Vol.55 (1), p.334-335

2017

Volltextzugriff (PDF)

Implementation of indication-based antibiotic order sentences improves antibiotic use in emergency departments

The American journal of emergency medicine, 2023-07, Vol.69, p.5-10

2023

Volltextzugriff (PDF)

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e1444-e1455

2023

Volltextzugriff (PDF)

Considerations for antibiotic prophylaxis in head and neck cancer surgery

Oral oncology, 2017-11, Vol.74, p.181-187

2017

Volltextzugriff (PDF)

You'll have to call the attending: Impact of a longitudinal, “real-time” case-based infectious diseases elective on entrustable professional activities to enhance APPE readiness

Currents in pharmacy teaching and learning, 2024-08, Vol.16 (8), p.102092, Article 102092

2024

Volltextzugriff (PDF)

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese

Open forum infectious diseases, 2023-09, Vol.10 (9), p.ofad454

2023

Volltextzugriff (PDF)

A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species

Antimicrobial agents and chemotherapy, 2019-05, Vol.63 (5)

2019

Volltextzugriff (PDF)

Retraction for Flynt et al., "Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam"

Journal of clinical microbiology, 2018-06, Vol.56 (6)

2018

Volltextzugriff (PDF)

Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus

Infectious diseases and therapy, 2024-11

2024

Volltextzugriff (PDF)

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections

Open forum infectious diseases, 2021-02, Vol.8 (2), p.ofab002-ofab002

2021

Volltextzugriff (PDF)

Antibiotic Prophylaxis and Incidence of Infection with External Ventricular Drains and Intra-Cranial Pressure Monitors

Surgical infections, 2022-04, Vol.23 (3), p.262-269

2022

Volltextzugriff (PDF)

26 – 50 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Infectious Diseases
(36)
Microbiology
(27)
Humans
(19)
Pharmacology & Pharmacy
(19)
Antimicrobial Stewardship
(13)
Antibiotics
(12)
Patients
(12)
Retrospective Studies
(12)
Immunology
(11)
Infections
(10)
Mortality
(10)
Methicillin
(9)
Risk Factors
(9)
Endocarditis
(8)
Health Aspects
(8)
Infective Endocarditis
(8)
Pseudomonas Aeruginosa
(8)
Anti-Bacterial Agents - Therapeutic Use
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections

Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales

Trowels and Tribulations: Review of Antimicrobial‐Impregnated Bone Cements in Prosthetic Joint Surgery

Incidence and Predictors of Gram-Negative Bacilli in Hospitalized People Who Inject Drugs with Injection Drug Use-Attributable Infections

Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections

Ceftriaxone versus cefepime or carbapenems for definitive treatment of low-risk AmpC-Harboring Enterobacterales bloodstream infections in hospitalized adults: A retrospective cohort study

Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe Infections

Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis

Candida spp. infective endocarditis: Characteristics and outcomes of twenty patients with a focus on injection drug use as a predisposing risk factor

Clinical Utility of Lefamulin: If Not Now, When?

Aminopenicillins vs non-aminopenicillins for treatment of enterococcal lower urinary tract infections

Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients With Diabetic Foot Infections

Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam

Implementation of indication-based antibiotic order sentences improves antibiotic use in emergency departments

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

Considerations for antibiotic prophylaxis in head and neck cancer surgery

You'll have to call the attending: Impact of a longitudinal, “real-time” case-based infectious diseases elective on entrustable professional activities to enhance APPE readiness

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese

A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species

Retraction for Flynt et al., "Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam"

Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections

Antibiotic Prophylaxis and Incidence of Infection with External Ventricular Drains and Intra-Cranial Pressure Monitors

Suchergebnisse filtern